참고문헌
- Nicol RW, Traquair JA, Bernards MA. Ginsenosides as host resistance factors in American ginseng (Panax quinquefolius). Can J Bot 2011;80:557-62. https://doi.org/10.1139/b02-034
- Cho WCS, Chung WS, Lee SKW, Leung AWN, Cheng CHK. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 2006;550:173-9. https://doi.org/10.1016/j.ejphar.2006.08.056
- Wang T, Guo RX, Zhou GH, Zhou XD, Kou ZZ, Sui F, Li C, Tang LY, Wang ZJ. Traditional uses, botany, phytochemistry, pharmacology and toxicology of Panax notoginseng (Burk.) F.H. Chen: a review. J Ethnopharmacol 2016;188:234-58. https://doi.org/10.1016/j.jep.2016.05.005
- Yang WZ, Hu Y, Wu WY, Ye M, Guo DA. Saponins in the genus Panax L. (Araliaceae): a systematic review of their chemical diversity. Phytochemistry 2014;106:7-24. https://doi.org/10.1016/j.phytochem.2014.07.012
- Gao B, Huang LF, Liu HS, Wu H, Zhang EY, Yang L, Wu XJ, Wang ZT. Platelet P2Y12 receptor involved in the hemostatic effect of notoginsenoside Ft1, a saponin isolated from Panax notoginseng. Br J Pharmacol 2014;171:214-23. https://doi.org/10.1111/bph.12435
- Gao B, Shi HL, Li X, Qiu SP, Wu H, Zhang BB, Wu XJ, Wang ZT. p38 MAPK and ERK1/2 pathways are involved in the pro-apoptotic effect of notoginsenoside Ft1 on human neuroblastoma SH-SY5Y cells. Life Sci 2014;108:63-70. https://doi.org/10.1016/j.lfs.2014.05.010
- Shen KK, Ji LL, Gong CY, Ma YB, Yang L, Fan Y, Hou MQ, Wang ZT. Notoginsenoside Ft1 promotes angiogenesis via HIF-1a mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways. Biochem Pharmacol 2012;84:784-92. https://doi.org/10.1016/j.bcp.2012.05.024
- Shen KK, Leung SWS, Ji LL, Huang Y, Hou MQ, Xu AM, Wang ZT, Vanhoutte PM. Notoginsenoside Ft1 activates both glucocorticoid and estrogen receptors to induce endothelium-dependent, nitric oxide-mediated relaxations in rat mesenteric arteries. Biochem Pharmacol 2014;88:66-74. https://doi.org/10.1016/j.bcp.2014.01.007
- Zhang JJ, Ding LL, Wang BC, Ren GY, Sun AN, Deng C, Wei XH, Mani S, Wang ZT, Dou W. Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation. J Pharmacol Exp Ther 2015;352:1-10.
- Deng J, Jiang YX, Ying-Li C, Chen XQ. Effects of ginsenoside CK on gastric cancer SGC-7901 cell line and endogenous VEGF secreted by tumor cells. Cancer Res Prev Treat 2011;38:17-20.
- Oh M, Choi YH, Choi S, Chung H, Kim K. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999;14:869-75.
- Tsutsumi YM, Tsutsumi R, Mawatari K, Nakaya Y, Kinoshita M, Tanaka K, Oshita S, Compound K. A metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway. Life Sci 2011;88:725-9. https://doi.org/10.1016/j.lfs.2011.02.011
- Shin KO, Seo CH, Cho HH. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells. Arch Pharmacol Res 2014;37:1183-92. https://doi.org/10.1007/s12272-014-0340-6
- Mai TT, Moon JY, Song YW. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett 2012;321:144-53. https://doi.org/10.1016/j.canlet.2012.01.045
- Siraj FM, SathishKumar N, Kim YJ. Ginsenoside F2 possesses anti-obesity activity via binding with PPAR and inhibiting adipocyte differentiation in the 3T3-L1 cell line. J Enzym Inhib Med Ch 2014;30:9-14. https://doi.org/10.3109/14756366.2013.871006
- Wei XJ, Chen J, Su F, Su XY, Hu TJ, Hu SH. Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in mice. Int Immunol 2012;24:465-71. https://doi.org/10.1093/intimm/dxs043
- Pi MS, Ru Q, Gong XK, Wu RH, Tian X, Xiong Q, Li CY. Effect of ginsenoside Rg2 and its stereoisomers on oxygen-glucose deprivation and reperfusion induced cortical neuronal injury model. Chin J Integr Tradit West Med 2016;36:333-8.
- Yang XD, Yang YY, Ouyang DS, Yang GP. A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia 2015;100:208-20. https://doi.org/10.1016/j.fitote.2014.11.019
- Yan Q, Zhou XW, Zhou W, Li XW, Feng MQ, Zhou P. Purification and properties of a novel beta-glucosidase, hydrolyzing ginsenoside Rb1 to CK, from Paecilomyces bainier. J Microbiol Biotechnol 2008;18:1081-9.
- Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 2002;25:743-7. https://doi.org/10.1248/bpb.25.743
- Zhou W, Feng MQ, Li JY, Zhou P. Studies on the preparation, crystal structure and bioactivity of ginsenoside compound K. J Asian Nat Prod Res 2006;8:519-27. https://doi.org/10.1080/10286020500208600
- Quan LH, Kim YJ, Li GH, Choi KT, Yang DC. Microbial transformation of ginsenoside Rb1 to compound K by Lactobacillus paralimentarius. World J Microbiol Biotechnol 2013;29:1001-7. https://doi.org/10.1007/s11274-013-1260-1
- Wang RF, Zheng MM, Cao YD, Li H, Li CX, Xu JH, Wang ZT. Enzymatic transformation of vina-ginsenoside R7 to rare notoginsenoside ST-4 using a new recombinant gylcoside hydrolase from Herpetosiphon aurantiacus. Appl Microbiol Biotechnol 2015;99:3433-42. https://doi.org/10.1007/s00253-015-6446-z
- Wang RF, Li J, Hu HJ, Li J, Yang YB, Yang L, Wang ZT. Chemical transformation and target preparation of saponins in stems and leaves of Panax notoginseng. J Ginseng Res 2018;42:270-6. https://doi.org/10.1016/j.jgr.2016.08.009
- Yan X, Fan Y, Wei W, Wang PP, Liu QF, Wei YJ, Zhang L, Zhao GP, Yue JM, Zhou ZH. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Res 2014;24:770-3. https://doi.org/10.1038/cr.2014.28
- Liu MH, Yang BR, Cheung WF, Yang KY, Zhou HF, Kwok JS, Liu GC, Li XF, Zhong S, Lee SM, et al. Transcriptome analysis of leaves, roots and flowers of Panax notoginseng identifies genes involved in ginsenoside and alkaloid biosynthsis. BMC Genomics 2015;16:1-12. https://doi.org/10.1186/1471-2164-16-1
- Luo SL, Dang LZ, Zhang KQ, Liang LM, Li GH. Cloning and heterologous expression of UDP-glycosyltransferase genes from Bacillus subtilis and its application in the glycosylation of ginsenoside Rh1. Lett Appl Microbiol 2014;60:72-8. https://doi.org/10.1111/lam.12339
- Xu P, Vansiri A, Bhan N, Koffas MAG. ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli. ACS Synth Biol 2012;1:256-66. https://doi.org/10.1021/sb300016b
- Zhao SJ, Jones JA, Lachance DM, Bhan N, Khalidi O, Venkataraman S, Wang ZT, Koffas MA. Improvement of catechin production in Escherichia coli through combinatorial metabolic engineering. Metab Eng 2015;28:43-53. https://doi.org/10.1016/j.ymben.2014.12.002
- Liu L, Zhu XM, Wang QJ, Zhang DL, Fang ZM, Wang CY, Wang Z, Sun BS, Wu H, Sung CK. Enzymatic preparation of 20(S, R)-protopanaxadiol by transformation of 20(S,R)-Rg3 from black ginseng. Phytochemistry 2010;71:1514-20. https://doi.org/10.1016/j.phytochem.2010.05.007
- Wang PP, Wei YJ, Fan Y, Liu QF, Wei W, Yang CS, Zhang L, Zhao GP, Yue JM, Yan X, et al. Production of bioactive ginsenosides Rh2 and Rg3 by metabolically engineered yeasts. Metab Eng 2015;29:97-105. https://doi.org/10.1016/j.ymben.2015.03.003
- Jung SC, Kim W, Park SC, Jeong J, Park MK, Lim S, Lee Y, Im WT, Lee JH, Choi G, et al. Two ginseng UDP-glycosyltransferases synthesize ginsenoside Rg3 and Rd. Plant Cell Physiol 2014;55:2177-88. https://doi.org/10.1093/pcp/pcu147
피인용 문헌
- miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1 vol.10, 2020, https://doi.org/10.3389/fonc.2020.01509
- Efficacy of Panax ginseng Meyer Herbal Preparation HRG80 in Preventing and Mitigating Stress-Induced Failure of Cognitive Functions in Healthy Subjects: A Pilot, Randomized, Double-Blind, Placebo-Co vol.13, pp.4, 2019, https://doi.org/10.3390/ph13040057
- Biocatalytic strategies for the production of ginsenosides using glycosidase: current state and perspectives vol.104, pp.9, 2019, https://doi.org/10.1007/s00253-020-10455-9
- Highly efficient production of diverse rare ginsenosides using combinatorial biotechnology vol.117, pp.6, 2019, https://doi.org/10.1002/bit.27325
- The chromosome-level reference genome assembly for Panax notoginseng and insights into ginsenoside biosynthesis vol.2, pp.1, 2019, https://doi.org/10.1016/j.xplc.2020.100113
- One-Pot Bi-Enzymatic Cascade Synthesis of Novel Ganoderma Triterpenoid Saponins vol.11, pp.5, 2019, https://doi.org/10.3390/catal11050580
- Single site mutations of glycosyltransferase with improved activity and regioselectivity for directed biosynthesis of unnatural protopanaxatriol-type ginsenoside product vol.515, 2019, https://doi.org/10.1016/j.mcat.2021.111937